Articles related to HEALTHCARE DISPARITIES

“Without our participation and inclusion in clinical research, the drugs and treatments being developed might not actually help improve our quality of life or prolong it, as researchers will not have the opportunity to see how we specifically respond to these treatments.” – Audrey Davis, LPC, PM-LPC, Senior Director, Health Equity at the Cancer Support Community

Nurses can gain insights into how genetic and environmental factors contribute to obesity among different racial groups. Understanding epigenetic factors can help develop more effective, culturally sensitive interventions.

Among pediatric gastroenterologists, there is agreement that ALT ≥ 22 U/L for boys and ALT ≥ 22 U/L for girls should be the cutoffs when to determine the ALT levels are increased.

“We’re lucky to have found it at this stage where I could say the word cure, because I don’t use that word lightly as a cancer doctor.” – Dr. Janet Kukreja, the Director of Urologic Oncology at the CU Cancer Center/UC Health University of Colorado Hospital

The average change in HbA1c from initial visit to discharge was –2.68% in patients who graduated and –0.47% in those who were discharged—quite significant, given that every 1% reduction in HbA1c translates into a 14% decrease in the risk for heart attack.

Activity levels in case participants began declining approximately 12 years before cardiovascular disease diagnosis, with accelerated declines within two years of the event.